NIH-funded research Fellowship grant

Exploring how bacteria resist multiple antibiotics

Official title: Understanding the Molecular Rules of a Bacterial Multidrug Efflux Transporter

Funded at University of Wisconsin-Madison · NIH-11160998 · Data updated 2026-11-12

This study is looking at how some bacteria can fight off many antibiotics using special proteins, and it's for anyone interested in understanding how we might find new ways to tackle antibiotic resistance in healthcare.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startJune 1, 2025
Project endMay 31, 2027
Funding year2025
Award (this year)$36,304
NIH project number1F31AI186356-01A1
Project IDNIH-11160998 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria.

Less likely to help

Patients with infections that are not caused by antibiotic-resistant bacteria may not benefit from this research.

What this research studies

This research investigates how certain bacteria can effectively resist a wide range of antibiotics through specialized proteins known as multidrug efflux pumps. By examining the molecular mechanisms behind these pumps, the study aims to identify how they can export various antibiotics while selectively retaining harmful substances. The approach involves creating and testing thousands of mutant versions of a specific protein to understand the factors that contribute to antibiotic resistance. This research could provide insights into new strategies for overcoming antibiotic resistance in clinical settings.

Why it matters

Potential benefit: If successful, this research could lead to the development of new treatments that enhance the effectiveness of existing antibiotics against resistant bacterial infections.

How similar studies have gone: Previous research has shown promising results in understanding antibiotic resistance mechanisms, making this approach a continuation of established scientific inquiry.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Miller, Silas — University of Wisconsin-Madison
  • Study coordinator: Miller, Silas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.